In summary, our data demonstrate that FGFR3-IIIc exerts oncogenic effects in colorectal cancer cells by promoting in vitro tumour cell growth, survival, migration and responsiveness to oncogenic FGF ligands such as FGF18. This evidence concerns the gene FGF18 and colorectal cancer.